We use the most advanced technology to perform genetic testings which detect both,  pathogenetic mutations in responsibles genes of neoplastic diseases, and structural genetic variations which may be involved in these diseases.

Together with the results of the requested analysis, WG produces a clinical report which pretends to support the oncologist with the choice of the most adequate treatment for a given patient. It suggest which drug classes may be more adequate or less adequate for a that genetic profile. In summary, it informs how the patient can react to a given treatment.

Check out our portfolio for more information!

 

null

Whole genetic analysis

• Whole genome analysis (WGS)
• Whole exome analysis (WES)
• Whole transcriptome analysis (WTS)

Read more...

null

Panels for cancer diagnosis

• NGS panels for certain cancer types
• NGS panel for 48 relevant genes in cancer diagnosis
• NGS panel for 605 whole genes

Read more...

null

Analysis of specific genes

• Genetic test for specific mutations
• Fluorescence in situ hybridization (FISH) test
• Immunohistochemistry (IHC) test

Read more...

null

Coordination and Support in R+D+I projects

Whole Genix was founded on the concept of translational medicine, which approximates the latest scientific advances to the conventional clinical medicine.
Whole Genix evaluates the scientific advances in biomedicine and uses those which could be reused for the diagnosis or an improvement of the patients’ treatment in diseases with a significant social impact.

For more detailed information,  contact with us or subscribe to our newsletter

Tel. (+34) 93 445 39 30
Fax: (+34) 93 228 78 99
info@wholegenix.com